Alumis (ALMS) Cash & Current Investments (2023 - 2025)

Alumis' (ALMS) quarterly Cash & Current Investments came in at $308.5 million in Q4 2025, up 7.02% year-on-year from $288.3 million in Q4 2024, and down 18.33% on a QoQ basis from $377.7 million in Q3 2025.

Alumis (ALMS) Cash & Current Investments (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Cash & Current Investments data on file, last reported at $308.5 million in Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 7.02% year-over-year to $308.5 million in Q4 2025; TTM through Dec 2025 was $308.5 million, a 7.02% increase from a year earlier, with the FY2025 full-year figure at $308.5 million, up 7.02% from the prior year.
  • Cash & Current Investments for Q4 2025 stood at $308.5 million, down from $377.7 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for ALMS reached as high as $377.7 million in Q3 2025 and fell as low as $49.0 million in Q4 2023.
  • Historically, Cash & Current Investments has averaged $195.2 million across 3 years, with a median of $155.2 million in 2024.
  • Across the five-year window, Cash & Current Investments jumped 566.97% in 2024 and dropped 2.0% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $49.0 million in 2023, then soared by 488.87% to $288.3 million in 2024, then gained by 7.02% to $308.5 million in 2025.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $308.5 million in Q4 2025, $377.7 million in Q3 2025, and $152.1 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 65,839.48 Bn 65,839.20 Bn - 283.54 Mn
2 Nanobiotix 1,912.79 Bn 1,912.72 Bn - 61.40 Mn
3 Akari Therapeutics 1,015.37 Bn 1,015.37 Bn - -
4 BeOne Medicines 471.39 Bn 466.59 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 122.52 Bn 115.28 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 70.33 Bn 61.58 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.74 Bn 62.74 Bn - -
8 Argenx Se 56.10 Bn 50.91 Bn 1.41 Bn 5.18 Bn
9 Alnylam Pharmaceuticals 37.52 Bn 34.51 Bn 959.66 Mn 3.01 Bn
10 Alumis 2.37 Bn 2.06 Bn - 308.50 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 308.50 Mn
Sep 30, 2025 377.72 Mn
Jun 30, 2025 152.12 Mn
Mar 31, 2025 208.75 Mn
Dec 31, 2024 288.26 Mn
Sep 30, 2024 361.87 Mn
Jun 30, 2024 155.22 Mn
Mar 31, 2024 112.07 Mn
Dec 31, 2023 48.95 Mn
Sep 30, 2023 54.26 Mn
Jun 30, 2023 79.77 Mn